Literature DB >> 2168417

The phagocyte 47-kilodalton cytosolic oxidase protein is an early reactant in activation of the respiratory burst.

M E Kleinberg1, H L Malech, D Rotrosen.   

Abstract

Activation of the phagocyte NADPH oxidase requires participation of membrane-bound cytochrome b558 and cytosol proteins of 47 kDa (p47) and 67 kDa (p67). We examined the sequence of participation of p47 and p67 in activation of the oxidase using an arachidonate-activated cell-free superoxidase (O2-) generating assay requiring phagocyte membrane and cytosol. Neutrophil cytosol from patients with certain forms of autosomal recessive chronic granulomatous disease (CGD) lack either p47 or p67. Initial incubation of membrane and arachidonate with CGD cytosol deficient in either p47 or p67 fails to generate superoxide in the cell-free assay until addition of complementary cytosol. CGD cytosol was incubated with arachidonate and membrane for 5-15 min and the lag time of O2- generation was measured after addition of complementary CGD cytosol. The lag time is shortened when p47, but not p67, is present in the initial incubation. We have previously shown that the peptide, RGVHFIF, corresponding to a cytoplasmic carboxyl-terminal domain of the large subunit of cytochrome b558, inhibits activation of NADPH oxidase in the cell-free assay, but does not affect the enzyme activity of fully assembled oxidase. Experiments with sequential addition of complementary CGD cytosols were performed as above, except that RGVHFIF was added after the initial incubation. The peptide failed to inhibit when added after initial incubation if p47 was present during that incubation. In contrast, the peptide markedly inhibited oxidase activity if p47 was absent during the initial incubation. These results suggest that p47, but not p67, is a participant with membrane and/or other cytosol components in early arachidonate-dependent reactions. In the absence of p67, these reactions culminate in the irreversible formation of a metastable activation intermediate that is insensitive to inhibition by RGVHFIF. After addition of p67, this activation intermediate subsequently reacts to form the active NADPH oxidase.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2168417

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  Interaction of human neutrophil flavocytochrome b with cytosolic proteins: transferred-NOESY NMR studies of a gp91phox C-terminal peptide bound to p47phox.

Authors:  E R Adams; E A Dratz; D Gizachew; F R Deleo; L Yu; B D Volpp; M Vlases; A J Jesaitis; M T Quinn
Journal:  Biochem J       Date:  1997-07-01       Impact factor: 3.857

Review 2.  NADPH oxidases: an overview from structure to innate immunity-associated pathologies.

Authors:  Arvind Panday; Malaya K Sahoo; Diana Osorio; Sanjay Batra
Journal:  Cell Mol Immunol       Date:  2014-09-29       Impact factor: 11.530

3.  Mapping sites of interaction of p47-phox and flavocytochrome b with random-sequence peptide phage display libraries.

Authors:  F R DeLeo; L Yu; J B Burritt; L R Loetterle; C W Bond; A J Jesaitis; M T Quinn
Journal:  Proc Natl Acad Sci U S A       Date:  1995-07-18       Impact factor: 11.205

4.  Mechanisms of NADPH oxidase activation: translocation of p40phox, Rac1 and Rac2 from the cytosol to the membranes in human neutrophils lacking p47phox or p67phox.

Authors:  S Dusi; M Donini; F Rossi
Journal:  Biochem J       Date:  1996-03-01       Impact factor: 3.857

5.  Inhibitory effect of porcine surfactant on the respiratory burst oxidase in human neutrophils. Attenuation of p47phox and p67phox membrane translocation as the mechanism.

Authors:  W Chao; R G Spragg; R M Smith
Journal:  J Clin Invest       Date:  1995-12       Impact factor: 14.808

6.  A point mutation in gp91-phox of cytochrome b558 of the human NADPH oxidase leading to defective translocation of the cytosolic proteins p47-phox and p67-phox.

Authors:  J H Leusen; M de Boer; B G Bolscher; P M Hilarius; R S Weening; H D Ochs; D Roos; A J Verhoeven
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

7.  Regulation of NADPH oxidase activity by Rac GTPase activating protein(s).

Authors:  P G Heyworth; U G Knaus; J Settleman; J T Curnutte; G M Bokoch
Journal:  Mol Biol Cell       Date:  1993-11       Impact factor: 4.138

Review 8.  Strategies for identifying synthetic peptides to act as inhibitors of NADPH oxidases, or "all that you did and did not want to know about Nox inhibitory peptides".

Authors:  Iris Dahan; Edgar Pick
Journal:  Cell Mol Life Sci       Date:  2012-05-06       Impact factor: 9.261

Review 9.  Activation and assembly of the NADPH oxidase: a structural perspective.

Authors:  Yvonne Groemping; Katrin Rittinger
Journal:  Biochem J       Date:  2005-03-15       Impact factor: 3.857

Review 10.  NOX enzymes as novel targets for drug development.

Authors:  J David Lambeth; Karl-Heinz Krause; Robert A Clark
Journal:  Semin Immunopathol       Date:  2008-05-29       Impact factor: 11.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.